Arboretum Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.
BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US
Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)
BoardJacob Robinson(Co-founder & CEO)in
Board seatThomas M. Shehab· per SEC Form D
Co-investorsPsyMed VenturesTMC Venture FundCapital FactoryDivergent CapitalDolby Family VenturesKdT Ventures+2 more
Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.
Digital HealthHealthtechMedical DevicesValencia, US
Jill Schiaparelli(Executive Officer, Director)Kevin Wasserstein(Director)
BoardThomas Shehab, MD(Director)
Co-investorsAngelini VenturesShangBay Capital LLCAvestria Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.